iBio, Inc.

iBio, Inc. is a biotechnology company that focuses on the development and commercialization of plant-based biopharmaceuticals. Leveraging proprietary technologies and a unique platform called FastPharming, iBio accelerates the production of recombinant proteins for use in vaccines, therapeutics, and diagnostics. This platform capitalizes on the rapid growth and scalability of plants to offer a sustainable alternative to traditional drug manufacturing. iBio's operations are particularly relevant in healthcare sectors addressing urgent needs, such as infectious disease prevention and cancer treatment. Situated at the intersection of biotech innovation and agribusiness, the company's contributions are vital in enhancing production efficiencies and reducing costs associated with pharmaceutical development. iBio, Inc., by integrating plant-based solutions, is progressively impacting markets where rapid response and cost-effective production are critical factors.